Identification of nanomolar adenosine A2A receptor ligands using reinforcement learning and structure-based drug design
Abstract Generative chemical language models (CLMs) have demonstrated success in learning language-based molecular representations for de novo drug design. Here, we integrate structure-based drug design (SBDD) principles with CLMs to go from protein structure to novel small-molecule ligands, without...
Saved in:
| Main Authors: | Morgan Thomas, Pierre G. Matricon, Robert J. Gillespie, Maja Napiórkowska, Hannah Neale, Jonathan S. Mason, Jason Brown, Kaan Harwood, Charlotte Fieldhouse, Nigel A. Swain, Tian Geng, Noel M. O’Boyle, Francesca Deflorian, Andreas Bender, Chris de Graaf |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60629-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preparation and validation of nanomolar aqueous bilirubin standard solutions
by: Paola Sist, et al.
Published: (2025-06-01) -
EFFECTS OF ADENOSINE RECEPTOR LIGANDS ON THE NOCICEPTION AND STRESS-INDUCED ANTINOCICEPTION IN MICE
by: Lubomira Ivanova, et al.
Published: (2019-02-01) -
Molecular basis of ligand binding and receptor activation at the human A3 adenosine receptor
by: Liudi Zhang, et al.
Published: (2025-08-01) -
Discovery of 2‑Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents
by: Tejaswini P. Siddappa, et al.
Published: (2025-01-01) -
Synthetic Small-Molecule Ligands Targeted to Adenosine Receptors: Is There Potential Towards Ischemic Heart Disease?
by: Qi Xu, et al.
Published: (2025-08-01)